The US Biocatalysis & Biocatalysts Market is experiencing significant growth due to increased demand for sustainable industrial processes and advancements in enzyme engineering. The market size was valued at USD 1,420 Million in 2025 and is expected to reach USD 3,855 Million by 2035, growing at a CAGR of 9.3% from 2024 to 2035.
The economic impact of tariffs on "US Biocatalysis & Biocatalysts Market".
US Biocatalysis & Biocatalysts Market Growth Drivers
Rising Demand for Sustainable Manufacturing: Increasing environmental regulations and the urgent need for greener and more sustainable chemical processes are driving widespread adoption of biocatalysts. For instance, Codexis, Inc. has developed more efficient enzyme solutions enabling pharmaceutical and chemical manufacturers to reduce waste, energy use, and carbon emissions.
Advancements in Enzyme Engineering: Technological advancements in protein and enzyme engineering, such as directed evolution and CRISPR, have enhanced the efficiency and stability of biocatalysts. Novozymes has leveraged advanced bioengineering to launch enhanced enzyme variants for the food and beverage, and biofuel sectors, improving conversion rates and process yields.
US Biocatalysis & Biocatalysts Market Trends
Emergence of Immobilized Enzyme Technologies: Immobilized enzyme systems are gaining traction due to their improved operational stability, reusability, and ease of separation from reaction mixtures. Companies like DuPont are investing in immobilized enzyme technologies for cost-effective and efficient catalysis in industrial applications.
Shift Towards Biocatalytic Synthesis of Pharmaceuticals: The pharmaceutical industry is increasingly adopting biocatalytic routes for complex molecule synthesis, driven by high selectivity and mild reaction conditions. Pfizer, for example, has incorporated biocatalysts into several drug manufacturing workflows, reducing the number of processing steps and improving yield.
US Biocatalysis & Biocatalysts Market Opportunities
Expansion in Bio-based Polymer Production: Growing demand for bio-based polymers presents significant opportunities for biocatalysts manufacturers, as biocatalytic processes offer environmentally-friendly alternatives to traditional chemical syntheses. Companies like BASF are investing in this sector to capitalize on sustainable raw material trends.
Increasing Adoption in Agrochemical Sector: The surge in demand for sustainable and selective agrochemical production is opening new avenues for biocatalysis. Evonik Industries has developed biocatalyst-based processes for efficient synthesis of crop protection products, ensuring lower environmental impact.
US Biocatalysis & Biocatalysts Market Revenue (USD Million), 2020-2035
The market revenue chart illustrates the steady and robust growth of the US Biocatalysis & Biocatalysts market over the period from 2020 to 2035. The chart indicates an acceleration in market growth after 2025, supported by technological progress and new application areas. By 2030, revenues surpass USD 2,290 Million and reach an estimated USD 3,855 Million in 2035. The consistent uptrend highlights the sector’s increasing relevance within the US chemicals and biotech industries.
US Biocatalysis & Biocatalysts Market by Regional Share (%) in 2025
The pie chart represents the regional distribution of the US Biocatalysis & Biocatalysts market share in 2025. The Midwest, driven by a strong biotechnology and chemical manufacturing base, leads with a 33% share. The Northeast follows due to pharmaceutical activity (28%), then the West (21%), South (15%), and Other regions (3%). This regional disparity underscores the concentration of industry-leading companies and research institutions in specific US geographies.
US Biocatalysis & Biocatalysts Market Recent Developments (last 6 months)
In April 2024, Codexis, Inc. announced the launch of its next-generation CODEX HiFi Biocatalyst platform, which offers unprecedented performance and cost savings for pharmaceutical and food manufacturing customers. This enables faster process optimization and expanded substrate scope for industrial biocatalysis.
In February 2024, Novozymes entered into a strategic partnership with a leading US specialty chemicals company to co-develop customized enzyme solutions for the bio-based polymer sector. This collaboration targets the growing market for green manufacturing and renewable material solutions.
In March 2024, DuPont celebrated the successful deployment of new immobilized enzyme technology at its Iowa manufacturing plant. This innovation is set to reduce water and energy consumption by over 20% and expand the company’s capacity to produce bio-based chemicals with higher efficiency.
Press Releases